Hide Board Information

Show Board Information

Tasman Resources NL TAS

Board Mod: Add me as mod

Asst Mods:

Last Post: 06/04/2012 1:22:00 AM

Board Marks: 0

Posts Today: 0

Board Views Today: 3

Tasman Resources NL (TAS) Stock Message Board

Find TAS Recent News, TAS Filings, TAS Stock Quote, TAS Stock Chart, TAS Research & Opinions Below

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

Be the first to post on Tasman Resources NL TAS

Recent Articles

• Rémy Cointreau's Financial Performance: Analysis and Outlook
• Shanghai Promotion Conference Highlights Global Service Growth
• Major Milestone Achieved as Amaroq Minerals Pours First Gold
• ZetaDisplay AB Reports Significant Growth in Q3 2024
• Serabi Gold Reports Strong Financial Performance
• PayPoint Takes Strategic Step with Share Buyback Initiative
• Essential Financial Timeline for AS Tallink Grupp in 2025
• AS Infortar Announces Financial Reporting Timeline for 2025
• Falcon Oil & Gas Ltd. Reports Strong Financial Progress in 2024
• Key Financial Updates for AS Tallink Grupp in 2025
• Reima Rytsölä Steps Up as New CEO of Kojamo plc
• Sampo plc's Recent Share Buyback Insights and Impacts
• Strategic Alliance Between Dev4All and Pharmaseed Enhances R&D
• Rémy Cointreau Reveals Availability of Financial Report Online
• Getlink SE Faces Delays in ElecLink Operations Recovery
• Shenzhen's Transformative Influence on Global Branding and Quality
• Jiangsu's Transformation: Merging Rich History with Innovation
• Hexagon Purus ASA Reports Record Q3 Growth and Future Plans
• CTP Delivers State-of-the-Art Logistics Facility to Tesco
• Galderma's Nemolizumab Shows Promising Results for Itch Relief
• Explore Tokyo Psychodemic: An Immersive Gaming Experience
• Neos Corporation Unveils Enhanced Crayon Shin-chan App for iOS
• CoinEx Charity's Starlink Initiative Transforms Connectivity
• Zai Lab Boosts Patient Access to AUGTYRO for Lung Cancer
• Recursive Teams Up with Saudi Arabia for AI-Powered TB Solutions
• Akeso's Cadonilimab and Ivonescimab Added to National Drug List
• TeamT5 Earns Prestigious Recognitions in Cybersecurity Innovation
• Innovent Biologics Adds SINTBILO and Olverembatinib to NRDL
• Genesis Lifestyle Medicine Recognized for Stellar Leadership Achievement
• Genesis Lifestyle Medicine Earns Certified Amazing Workplace Honor
• Bridging Cultures: China and Europe's River Dialogues
• The Surge in Population Health Management: A $663.75 Billion Future
• Prime Mining Releases New Technical Report on Los Reyes Project
• Investigation Announced for Symbotic Inc. Shareholders
• Monument Mining Limited Reports Positive Q1 FY 2025 Results
• Strategic Alliance Between Sumitomo and Rikkeisoft Ignites Growth
• Innovative Approaches to Combat the Fall Armyworm Crisis
• Exro Technologies Faces Potential Class Action Suit
• BioArctic's Leqembi®: A New Hope for Alzheimer's Patients
• BioArctic Partners with Eisai for Leqembi Launch in Asia
• Rakovina Therapeutics Unveils New Financial Strategy for Growth
• Nonwoven Filtration Market Expected to Hit $8.4 Billion by 2028
• AIP Realty Trust Reports Q3 Financial Progress and Future Growth
• Weave Living and KKR Form Joint Venture to Enhance Japan's Housing Market
• Celsius Holdings Faces Legal Challenges—What Investors Should Know
• Lomiko Metals Secures Funding for La Loutre Graphite Project
• U.S. Gold Corp. Launches Significant $10.2 Million Offering
• Key Insights into the Growth of the Medical Nonwoven Market
• Exploring the Growth of the Portable Power Station Market
• Investors Alert: Class Action Update on Edwards Lifesciences